For the quarter ended June 2025, Clorox (CLX Quick QuoteCLX - Free Report) reported revenue of $1.99 billion, up 4.5% over the same period last year. EPS came in at $2.87, compared to $1.82 in the year-ago quarter.

The reported revenue represents a surprise of +3.04% over the Zacks Consensus Estimate of $1.93 billion. With the consensus EPS estimate being $2.24, the EPS surprise was +28.12%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Clorox performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic Revenue Growth - Health and Wellness: 14% compared to the 6.3% average estimate based on four analysts.
• Organic Revenue Growth - International: 1% versus the four-analyst average estimate of 2.4%.
• Organic Revenue Growth - Lifestyle: 3% compared to the 6.3% average estimate based on four analysts.
• Organic Revenue Growth - Household: 7% versus the four-analyst average estimate of 4.6%.
• Organic Sales Growth: 8% compared to the 5.4% average estimate based on four analysts.
• Net Revenue- Health and Wellness: $741 million compared to the $692.86 million average estimate based on four analysts. The reported number represents a change of +13.7% year over year.
• Net Revenue- International: $269 million compared to the $249.98 million average estimate based on four analysts. The reported number represents a change of -0.7% year over year.
• Net Revenue- Lifestyle: $339 million compared to the $349.59 million average estimate based on four analysts. The reported number represents a change of +3.4% year over year.
• Net Revenue- Household: $639 million compared to the $626.55 million average estimate based on four analysts. The reported number represents a change of +7% year over year.
• Income before income taxes- Health and Wellness: $243 million compared to the $219.1 million average estimate based on two analysts.
• Income before income taxes- Corporate and Other: $-56 million compared to the $-26.67 million average estimate based on two analysts.
• Income before income taxes- International: $23 million compared to the $21.21 million average estimate based on two analysts.

View all Key Company Metrics for Clorox here>>>

Shares of Clorox have returned +1.2% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.